Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 418
Filter
1.
2021 Ieee International Symposium on Medical Measurements and Applications (Ieee Memea 2021) ; 2021.
Article in English | Web of Science | ID: covidwho-2032315

ABSTRACT

The most frequent prodromes of COVID-19 infection are fever and signs/symptoms of incipient respiratory diseases such as cough and shortness of breath or tachypnea. However, it is not infrequent that in patients infected with COVID-19, in addition to respiratory manifestations, cardiac rhythm alterations are also present which can be an early sign of an acute cardiovascular syndrome. It is therefore of utmost importance, especially for health care and civil protection workers who are most exposed to the infection, to detect the prodromal symptoms of this infection in order to be able to make a diagnosis of possible positivity to COVID-19 infection as quickly as possible and therefore to provide their immediate insertion in the isolation/therapy protocols. Here a prototype of a smart face mask is presented: the AG47-SmartMask. In addition to having the function of both an active and passive anti COVID-19 filter, the latter by an electro-heated filter brought to a minimum temperature of 38 degrees C, the AG47-SmartMask also allows the continuous monitoring of numerous cardio-pulmonary variables. Several specific sensors are incorporated into the mask in an original way that assess the inside mask temperature, relative humidity and air pressure together with the auricular assessment of body temperature, heart rate and percentage of oxygen saturation of haemoglobin. Sensors work in synergy with an advanced telemedicine platform. To validate the device, twenty workers engaged in a vegetable packaging chain tested the tool simulating, while working, both tachypnea and cough, and the AG47-SmartMask faithfully quantified the simulated dyspnoic events.

2.
J Hosp Infect ; 2022.
Article in English | ScienceDirect | ID: covidwho-2031453

ABSTRACT

INTRODUCTION: The role of fomites in the transmission of SARS-CoV-2 is unclear. Our objective was to assess whether SARS-CoV-2 can be transmitted through fomites, using evidence from viral culture studies. METHODS: We conducted searches in the WHO Covid-19 Database, PubMed, LitCovid, medRxiv, and Google Scholar to 31 December 2021. We included studies that investigated fomite transmission and performed viral culture to assess the cytopathic effect (CPE) of positive fomite samples and confirmation of SARS-CoV-2 as the cause of the CPE. We assessed the risk of bias using a checklist modified from the QUADAS-2 criteria. RESULTS: We included 23 studies. The overall risk of bias was moderate. Five studies demonstrated replication-competent virus from fomite cultures and three used genome sequencing to match fomite samples with human clinical specimens. The mean Ct of samples with positive viral culture was significantly lower compared with cultured samples that returned negative results: SMD -1.45, 95%CI -2.00 to -0.90, I(2)=0%;P<0.00001. The likelihood of isolating replication-competent virus was significantly greater when the Ct was <30: RR 3.10 (95%CI 1.32 to 7.31, I(2)=71%, P=0.01). Infectious specimens were mostly detected within 7 days of symptom onset. One study showed possible transmission of SARS-CoV-2 from fomites to humans. CONCLUSION: The evidence from published studies suggests that replication-competent SARS-CoV-2 is present on fomites. Replication-competent SARS-CoV-2 is significantly more likely when the PCR Ct for clinical specimens and fomite samples is <30. Further studies should investigate the duration of infectiousness of SARS-CoV-2 and the frequency of transmission from fomites.

3.
Annals of Medicine and Surgery ; : 104648, 2022.
Article in English | ScienceDirect | ID: covidwho-2031105

ABSTRACT

Introduction In COVID-19 patients, Interleukin-6 (IL-6) will increase, and the production of antigens will be excessive, which will cause excessive inflammation of the tissues, especially the respiratory tract, which causes fibrosis in the lungs and can lead to death. Objective To analyze IL-6 expression of lung tissue in COVID-19 patient severity. Methods The study is an observational analytic design from July to December 2020. COVID-19 patient severity who died was examined for IL-6 expression on lung tissue. The lung tissue sampling uses the core biopsy method. Results The total number of samples obtained was 38 samples. Characteristics of patients with a mean age of patients were 48 years, male, the most common chief complaint was shortness of breath, mean symptom onset was 5 days, patient length of stay was 10 days, the most common cause of death was a combination of septic shock and ARDS and the most common comorbid diabetes mellitus. There is an increased WBC, neutrophils, platelets, procalcitonin, CRP, BUN, creatinine serum, AST, ALT, and D-dimer. In this study, the average tissue IL-6 expression was 72.63, with the highest frequency of strong positive 47.4%. Conclusion An increase in IL-6 expression on lung tissue showed the severity of COVID-19 infection.

4.
Laboratory Diagnostics. Eastern Europe ; 11(2):214-223, 2022.
Article in Russian | Scopus | ID: covidwho-2026636

ABSTRACT

Introduction. Patients hospitalized with COVID-19 are often prescribed broad-spectrum antibiotics that can contribute the selection and spread of antibiotic-resistant strains. Purpose. To identify carbapenemase production and the active efflux mechanisms for antibiotics of various classes in multidrug-and extensively drug-resistant Klebsiella pneumoniae and Acinetobacter baumannii strains isolated from patients with COVID-19 infection. Materials and methods. This study included 51 multidrug-and extensively drug-resistant Klebsiella pneumoniae strains and 47 multidrug-resistant strains of Acinetobacter baumannii isolated from patients with COVID-19 infection. The minimum inhibitory concentrations (MICs) for meropenem, imipenem, cefepime, ceftazidime, doxycycline, levofloxacin, tigecycline, rifampicin, chloramphenicol and amikacin were assessed by broth microdilution method for all investigated strains. Moreover, MICs of antibiotics in the presence of efflux pump inhibitor (carbonyl cyanide-chlorophenylhydrazone, CCCP) were determined. For phenotypic detection of metallo-β-lactamase (MBL) production the double-disk EDTA method was performed. Carbapenemase genes were detected by real-time PCR. Results. All of the isolated strains have demonstrated multidrug or extensively drug resistance. All strains of A.baumannii were resistant to carbapenems, levofloxacin, amikacin and were OXA-carbapenemase producers. Susceptibility to carbapenems remained only in 2.0–3.9% of K. pneumoniae strains, to amikacin – in 7.8% of strains. Carbapenemase production was detected in 68.6% of K. pneumoniae strains (NDM – 31.4%, OXA-48 – 23.5%, KPC – 2.0%, co-production of two carbapenemase – 11.8%). Inhibition of efflux pumps made it possible to reduce the MIC values for carbapenems, cephalosporins, levofloxacin, amikacin, tigecycline in 2.1–25.5% of A. baumannii and K. pneumoniae strains. On the other hand, it didn’t restore their susceptibility to antibiotics. Conclusion. Resistance to carbapenems and other β-lactams in A.baumannii and K. pneumoniae strains is associated with the production of carbapenemases. The presence of efflux mechanisms in some of the studied strains is an important, but not the only mechanism of antibiotic resistance. © 2022, Professionalnye Izdaniya. All rights reserved.

5.
Russian Journal of Gastroenterology, Hepatology, Coloproctology ; 31(6):16-22, 2021.
Article in English | Scopus | ID: covidwho-2026241

ABSTRACT

Introduction. Publications demonstrate some limitations of National Early Warning Score 2 (NEWS-2) accuracy in assessment on coronavirus infection severity. The purpose of this study was to determine the value of the patient’s age and routine laboratory parameters in the assessment of patient’s general condition in coronavirus pneumonia and their relation to NEWS-2 scale parameters. Materials and methods. 50 case reports of patients with COVID-19 infection observed in the Sechenov University in January–March 2021 were analyzed. 34 % of patients were males aged 31 to 89 years (average age 55 years) and 66 % — females aged 40 to 91 (mean age 63). The diagnosis of pneumonia was confirmed by computed tomography. NEWS-2 scale total score was assessed. Results. According to the physician’s subjective assessment the condition was significantly more often assessed as moderate and severe. There was only a weak correlation between the blood oxygen saturation and the total NEWS-2 score (r = 0.165, α = 0.1). We found a mild correlation (r = 0.341, α = 0.1) between the patient’s age and NEWS-2 score. Among the most significantly interrelated parameters were age, neutrophil count, serum creatinine, CRP, fibrinogen level. Seven interrelated parameters (age, body temperature, blood oxygen saturation, the neutrophils count, creatinine, CRP, fibrinogen), for which a reliable relation with other tests has been shown, were assigned with its special index according to their contribution to the assessment of the overall condition severity. An aggregated score (criterion X) was proposed for assessment of disease severity according to equation. The proportions of mild, moderate, and severe cases according to criterion X were 12 %, 64 % and 24 %. Conclusion. The preliminary results obtained in the study emphasize the importance of routine laboratory tests in assessment of coronavirus infection severity. An evident discrepancy between NEWS-2 score and X criterion may be very important for practice. © Russian Journal of Neurosurgery.All rights reserved.

6.
Egyptian Journal of Hospital Medicine ; 89(1):4332-4339, 2022.
Article in English | Scopus | ID: covidwho-2026197

ABSTRACT

Background: School closure was taken as one of the international measures to combat the COVID-19 pandemic. After the recession of the first wave of COVID-19, reopening of schools was decided to gain the educational and psychological support proposed by schools, on condition that they apply strict hygienic measures in schools and by students to prevent the spread of infection. Objective: This study aimed to estimate the degree to which school students committed to hygienic measures related to COVID-19 prevention as well as estimate schools' commitment to public health measures related to COVID-19 as reported by students. Patients and methods: A cross-sectional study was conducted in December 2020 on Egyptian school students. A stratified random sampling technique was used to select 20 basic education schools from the ten districts in Menoufia governorate, Egypt. A sample of 786 students were included and subjected to a self-administered questionnaire containing socio-demographic characteristics, students' commitment to hygienic measures related to COVID-19, and the commitment of the schools to preventive measures of COVID-19. Results: The studied students were 52.3% males with an average age ranging from 6 to 15 years. About 55.1% were from rural residences and 92% of them were with adequately educated mothers. Hand washing practice was mostly done after returning home from outside (95.2%). More than 95% of them wore masks at school entry but only 39.2% continued wearing them throughout the day. Students' commitment was significantly related to older age students, females, urban residence, and mother's education. Conclusion: Commitment of students to hygienic measures against COVID-19 improved mainly with increasing age, female sex, urban areas, and with higher education of mothers. Also, it was significantly correlated with the school's commitment score, so continuing health education and training of parents and students, especially those who are young, will improve students' commitment. © 2022, Ain Shams University Faculty of Medicine. All rights reserved.

7.
Egyptian Journal of Hospital Medicine ; 89(1):4260-4264, 2022.
Article in English | Scopus | ID: covidwho-2026196

ABSTRACT

Background: There is growing concerns that COVID-19 vaccination causes disruption to menstrual cycle. The study has showed that several women required gynecological visits claiming menstrual irregularities or abnormal uterine bleeding after the first and second doses of vaccination (regardless of the type of vaccine used). Objective: This study was conducted in the eastern province of Saudi Arabia to assess the effect of Covid-19 vaccination on the menstrual cycle of the women. Material and methods: It was a cross-sectional prospective study that was conducted by survey the post Covid-19 vaccinated women in the eastern province of Saudi Arabia. The sample size was calculated using a Fisher’s formula which was 344 women who have been vaccinated by Covid-19 vaccination. Results: A total of 343 women participated in this study. The mean age of the participants was 30.16 ± 18.20 years. More than forty two percent of the participants had one time Covid-19 infection while 5% was twice infected with Covid-19 virus. The vast majority of the participants (91.3%) were immuned by 2 vaccines. More than sixty percent (60.3%) of the participants were suffering from one and other menstruation irregularities after Covid-19 vaccination. 14% of them were suffering from the menstruation frequency longer than 35 days while 10.2% of them were suffering from the menstruation frequency shorter than 25 days. Conclusion: Coronavirus disease 2019 (COVID-19) vaccination is associated with change in menstrual cycle length, heavy menstruation and painful menstruation. Female with the age group of 15-24 years were 2 times more likely to develop menstruation cycle change. © 2022, Ain Shams University Faculty of Medicine. All rights reserved.

8.
Atemwegs- und Lungenkrankheiten ; 48(7):286-291, 2022.
Article in German | Scopus | ID: covidwho-2025144

ABSTRACT

We report the case of a 40-year-old previously lung-healthy male who became infected with SARS-CoV-2 from a named index person while working in charity care. He developed intrinsic bronchial asthma during its course. Discussed are bronchial hyperreactivity following viral infection, occupational accident and occupational disease (number 3101 – German register of occupational diseases). ©2022 Dustri-Verlag Dr. K. Feistle.

9.
Annals of Indian Psychiatry ; 6(2):169-175, 2022.
Article in English | Web of Science | ID: covidwho-2024699

ABSTRACT

Background: COVID infection is known to cause acute and long-term neuropsychiatric presentations. Coronavirus infections are known to have neuroinvasive potential with consequent neuropsychiatric manifestations. Materials and Methods: The study was conducted in a tertiary care hospital, and COVID-19-positive individuals were grouped based on the presence or absence of loss of smell (anosmia) or taste symptoms (ageusia). Group 1 without smell or taste disturbance, and Group 2 with smell or taste disturbance. Both groups were followed up for 6 months to assess the new onset of psychiatric illness. Results: The onset of new psychiatric illness was present in 8 out of 30 (26.66%) cases in group 2 when compared with 2 out of 30 (6.66%) cases in Group 1, with a relative risk of 4 (95% confidence interval 0.9247-17.3023). In 10 cases, the pattern of psychiatric illness was depression (16.66%), anxiety (6.6%), posttraumatic stress disorder (3.33%), acute psychosis (3.33%), and acute stress disorder (3.33%). Both groups were compared in terms of socio-demographic profile, inflammatory markers, and computed tomography severity score, and no significant difference was noted between the two. A relative risk of 4 indicates that COVID-19-infected individuals who lose their sense of smell or taste are more likely to develop new-onset psychiatric illness. Conclusion: Impact of COVID-19 on the central nervous system is very evident, and loss of smell or taste symptoms could be an early marker. Early recognition and prompt treatment with immunotherapy or newer therapies will prevent the emergence of psychiatric disturbance and its disability.

10.
Front Psychiatry ; 13:938111, 2022.
Article in English | PubMed | ID: covidwho-2022908

ABSTRACT

OBJECTIVE: We aim to examine infection risk and vaccine status of COVID-19 in attention deficit and hyperactivity disorder and evaluate the impact of demographic, clinical, and COVID-19-related factors on the infection status and behavioral avoidance of COVID-19. METHODS: This cross-sectional study assessed adults with attention deficit and hyperactivity disorder recruited from an outpatient psychiatry clinic. Patients and healthy controls completed a survey on sociodemographic data, COVID-19 infection status, and vaccine status. COVID-19 Disease Perception Scale, COVID-19 Avoidance Attitudes Scale, Attitudes toward COVID-19 Vaccine Scale, Adult Attention Deficit and Hyperactivity Disorder Self-report Screening Scale for DSM-5, Adult Attention Deficit and Hyperactivity Disorder Self-Report Scale Symptoms Checklist, Patient Health Questionnaire-9, and State-Trait Anxiety Inventory were applied. RESULTS: Ninety patients and 40 healthy controls participated. Patients did not differ from controls in COVID-19 infection and vaccine status, and behavioral avoidance of COVID-19. No demographic and clinical factor significantly affected the COVID-19 infection status. Patients scored higher than controls in the perception of COVID-19 as contagious (p = 0.038), cognitive avoidance of COVID-19 (p = 0.008), and positive attitudes toward the COVID-19 vaccine (p = 0.024). After adjustment of possible factors, a positive perception of the COVID-19 vaccine and a perception of COVID-19 as dangerous were the two factors significantly affecting behavioral avoidance of COVID-19 [R (2) = 0. 17, F(2) = 13.189, p < 0.0001]. CONCLUSION: Infection and vaccine status of COVID-19 in patients did not significantly differ from controls. No demographic and clinical factor significantly affected the COVID-19 infection status. Approximately four-fifths of the patients were fully vaccinated as recommended by national and global health organizations. This has increased the knowledge base showing that the COVID-19 vaccine is acceptable and receiving the vaccine is endorsed by ADHD patients. Attention deficit and hyperactivity disorder itself may provoke no kind of mental disturbance in sense of perception of the danger of this disease. Our findings have increased the knowledge base showing that the COVID-19 vaccine is acceptable and the actual practice of receiving the vaccine is endorsed in this population. Our message for practice would be to take into account not only the core symptoms and the comorbidities of the disorder but also the perception of the disease while exploring its link with COVID-19.

13.
Diagnostica ; 2022.
Article in English | Web of Science | ID: covidwho-2016566

ABSTRACT

The COVID-19 pandemic has posed significant challenges to (expectant) mothers of infants in terms of family health protection. To meet these challenges in a health literate manner, COVID-19 protective measures must be considered important and must also be implemented appropriately in everyday life. To this end, N = 343 (expectant) mothers of infants indicated (a) how important they considered 21 COVID-19 infection prevention measures, and (b) how well they succeeded in implementing them in their daily life (20 measures). We performed data analysis using exploratory factor analysis for ordinal data and latent class analysis. One- and two-dimensional models (CFI = .960 / .978;SRMR = .053 / .039) proved to appropriately explain maternal importance ratings. The items on successfully applying COVID-19 measures in daily life can be modeled by the 5 factors hygiene measures, contact with other people, public transportation, staying at home, and checking infection status (CFI = 0.977;SRMR = .036). Six latent classes can be distinguished. Despite the largest class (39 %), classes are characterized by selective or general applicability problems. Classes reporting problems in the applicability of the measures rated them as generally less important (eta = .582). Assessing and modelling importance and applicability of COVID-19 prevention measures allows for a psychometrically sound description of subjective perceptions and behaviors that are crucial for health literate practice in maternal daily life.

14.
International Journal of Infectious Diseases ; 122:553-558, 2022.
Article in English | Web of Science | ID: covidwho-2015428

ABSTRACT

Objectives: This study aims to assess the efficacy of a combination treatment of doxycycline and zinc in the primary prevention of COVID-19 infection in Tunisian health care workers compared with two control groups.Methods: We conducted a prospective, randomized, double-blind clinical trial over 5 months to deter-mine the efficacy of a preventive combination treatment dose of doxycycline (100 mg/day) and zinc (15 mg/day), compared with a single-dose treatment with doxycycline versus placebo. The effectiveness of preventive treatment was measured by the significant decline in the number of cases of COVID-19 infec-tion and/or a decrease in the viral load as determined by SARS-CoV-2 cycle threshold value using reverse transcription polymerase chain reaction tests.Results: We detected a significant decrease of SARS-CoV-2 infection in the group that received both doxycycline and zinc compared with other participants. We also demonstrated that COVID-19 infection was neither associated with diabetes ( P = 0.51) nor associated with hypertension ( P = 0.99), asthma ( P = 0.52), and chronic obstructive pulmonary disease ( P = 0.27).Conclusion: Our findings indicated that preventive therapy reduced the risk of SARS-CoV-2. These results suggest that the combination of doxycycline and zinc has a protective effect in patients with SARS-CoV-2 infection.(c) 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )

15.
JTCVS Open ; 2022.
Article in English | ScienceDirect | ID: covidwho-2008183

ABSTRACT

Objective The COVID -19 pandemic presents a high mortality rate amongst patients who develop severe acute respiratory distress syndrome (ARDS). The purpose of this study was to evaluate the outcomes of venovenous ECMO in COVID-19-related ARDS and identify the patients that benefit the most from this procedure. Methods Adult COVID-19 patients with severe ARDS requiring VV-ECMO support at four academic insititutions between March and October 2020 were included. Data were collected through retrospective chart reviews. Bivariate and multivariable analysis were performed with the primary outcome of in-hospital mortality. Results Fifty-one consecutive patients underwent VV-ECMO with a mean age of 50.4 years;64.7% were male. Survival to hospital discharge was 62.8%. Median ICU and hospitalization duration were 27.4 (IQR:17-37) and 34.5 days (IQR:23-43), respectively. Survivors and non-survivors had a median ECMO cannulation time of 11 days (IQR 8-18) and 17 days (IQR: 12-25). The average post decannulation length of stay was 17.5 days (IQR: 12.4-25) for survivors and 0 days for non-survivors (IQR 0-6 days). Only one non-survivor was able to be decannulated. Clinical characteristics associated with mortality between non-surviors and survivors included increasing age (p=0.0048), hemorrhagic stroke (p=0.0014), and post operative dialysis (p=0.0013)were associated with mortality in a bivariate model and retained statistical significance in a multivariable model. Conclusion This multicenter study confirms the effectiveness of VV-ECMO in selected critically ill patients with COVID-19-related severe ARDS. The survival of these patients is comparable to non-COVID-19-related ARDS.

16.
Cureus Journal of Medical Science ; 14(7), 2022.
Article in English | Web of Science | ID: covidwho-2006486

ABSTRACT

Coronavirus disease 2019 (COVID-19) is a disease caused by a novel strain of coronavirus and has resulted in a global pandemic. Information regarding the COVID-19 pathophysiology and its long-term impacts on humans is yet to be found. The knowledge about the COVID-19 infection's effects on the fetus is limited. The maternal to fetal transmission during various trimesters is not adequately studied. We present a case concerning maternal-to-fetal vertical transmission focusing on congenital infection.

17.
Cureus ; 14(5): e25264, 2022 May.
Article in English | MEDLINE | ID: covidwho-2006482

ABSTRACT

Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The patient's clinical course was not severe and had a full recovery after a week of treatment.

18.
European Journal of Medical Genetics ; : 104602, 2022.
Article in English | ScienceDirect | ID: covidwho-2004039

ABSTRACT

Patients with certain inherited metabolic disorders (IMD) are at high risk for metabolic decompensation with exposure to infections. The COVID-19 pandemic has been particularly challenging for health care providers dealing with IMD patients, in view of its unpredictable consequences in these patients. There is limited data in literature on evaluating the impact and the outcome of COVID-19 infection in these patients. This cross-sectional retrospective study on a large cohort of unvaccinated IMD patients, reviewed the incidence of COVID-19 infection, disease manifestation and outcome during the pandemic between November 2019 and July 2021. In this cohort of 1058 patients, 11.7% (n = 124) were infected with COVID-19. Their median age was 16 years (age range 2–42);57% (n = 71) were males. Post-exposure positive test was noted in 78% (n = 97) patients, while 19% (n = 24) had symptomatic diagnosis and three patients tested positive during pre-hospital visits screening. Most patients, 68.5% (n = 85) had mild COVID-19 related symptoms such as fever, cough, headache and diarrhea while 13.7% (n = 17) patients had no symptoms. Of twenty-two patients (17.7%) who required hospitalization, 16 were adults with various intoxication and energy metabolism disorders, who developed IMD related complications such as metabolic acidosis, hyperammonemia, acute pancreatitis, hypoglycemia, rhabdomyolysis and thrombosis. Ten patients needed intensive care management. The cohort death rate was 2.4% (3 patients). Overall, the clinical course of COVID-19 infection in these IMD patients was relatively mild except for patients with intoxication and energy metabolism disorders who had high risk of developing acute metabolic decompensation with severe complications.

19.
Indian Journal of Psychiatry ; 64, 2022.
Article in English | Web of Science | ID: covidwho-2003232
20.
Front Oncol ; 12: 901426, 2022.
Article in English | MEDLINE | ID: covidwho-1997472

ABSTRACT

Background: Acute severe forms of COVID-19 infection are more likely in cancer patients and growing attention has been given to the persistent symptoms of the disease after severe COVID-19. However, mild illness is the dominant clinical presentation of COVID-19 infection. To investigate patients' behavior and the short- and longer-term pattern of the disease in cancer patients with mild COVID infection, a longitudinal online survey was conducted for 16 months during the pandemic in a large cohort of cancer patients from a French COVID-19 hot spot. An online questionnaire was administered at three time points between the first wave of the pandemic in France and the fourth wave. The questionnaire was completed by 1415 to 2224 patients, which queried patients' demographics, their behavior, and COVID infection patterns. Seventy percent of the patients were female, and 40% had a comorbid condition. More than one-third of the participants had breast cancer, and half were survivors. The rate of infection was 30% during wave 1 and 10% in wave 4; most patients had a mild COVID-19 infection. Twenty-five percent of infected patients during wave 4 did not seek medical advice. At wave 4, 87% of the patients received at least one dose of vaccine. Systematic compliance to shielding measures decreased over time. The short-term pattern of mild COVID changed between wave 1 and wave 4. Twenty-two percent of infected patients experienced persistent signs for more than 6 months with a negative impact on sleep, social behavior, and increased consumption of stress-relieving drugs. Our results showed a high prevalence of long-lasting symptoms in cancer patients with mild COVID-19 infection and inadequate behavior toward the disease and prevention measures among patients.

SELECTION OF CITATIONS
SEARCH DETAIL